References
- 1. Lai AY, Kondo M: Identification of a bone marrow precursor of the earliest thymocytes in adult mouse. Proc Natl Acad Sci U S A. 2007, 104(15):6311-6.10.1073/pnas.0609608104185104717404232
- 2. Mortellaro A, Wong SC, Fric J, Ricciardi-Castagnoli P: The need to identify myeloid dendritic cell progenitors in human blood. Trends Immunol. 2010, 31(1):18-23.10.1016/j.it.2009.09.01019836307
- 3. Ogawa M, Larue AC, Watson PM, Watson DK: Hematopoietic stem cell origin of connective tissues. Exp Hematol. 2010, 38(7):540-7.10.1016/j.exphem.2010.04.00520412832
- 4. Phinney DG, Prockop DJ: Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells. 2007, 25(11):2896-902.10.1634/stemcells.2007-063717901396
- 5. Theise ND: Stem cell plasticity: recapping the decade, mapping the future. Exp Hematol. 2010, 38(7):529-39.10.1016/j.exphem.2010.04.01320438800
- 6. Catlin SN, Busque L, Gale RE, Guttorp P, Abkowitz JL: The replication rate of human hematopoietic stem cells in vivo. Blood. 2011, 117(17):4460-6.10.1182/blood-2010-08-303537309956821343613
- 7. Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT: Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 2006, 439(7076):599-603.10.1038/nature0424716382241
- 8. Kovačević-Filipović M, Petakov M, Hermitte F, Debeissat C, Krstić A, Jovcić G, Bugarski D, Lafarge X, Milenković P, Praloran V, Ivanović Z: Interleukin-6 (IL-6) and low O(2) concentration (1%) synergize to improve the maintenance of hematopoietic stem cells (pre-CFC). J Cell Physiol. 2007, 212(1):68-75.10.1002/jcp.2100317311290
- 9. Frenette PS, Pinho S, Lucas D, Scheiermann C: Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol. 2013, 31:285-316.10.1146/annurev-immunol-032712-09591923298209
- 10. Liu ZJ, Zhuge Y, Velazquez OC: Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009, 106(6):984-91.10.1002/jcb.2209119229871
- 11. Golan K, Vagima Y, Ludin A, Itkin T, Cohen-Gur S, Kalinkovich A, Kollet O, Kim C, Schajnovitz A, Ovadya Y, Lapid K, Shivtiel S, Morris AJ, Ratajczak MZ, Lapidot T: S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. Blood. 2012, 119(11):2478-88.10.1182/blood-2011-06-358614
- 12. Hopman RK, DiPersio JF: Advances in stem cell mobilization. Blood Rev. 2014, 28(1):31-40.10.1016/j.blre.2014.01.001
- 13. Hoggatt J, Mohammad KS, Singh P, Hoggatt AF, Chitteti BR, Speth JM, Hu P, Poteat BA, Stilger KN, Ferraro F, Silberstein L, Wong FK, Farag SS, Czader M, Milne GL, Breyer RM, Serezani CH, Scadden DT, Guise TA, Srour EF, Pelus LM: Differential stem- and progenitor-cell trafficking by prostaglandin E2. Nature. 2013, 495(7441):365-9.10.1038/nature11929
- 14. Wang W, Li C, Pang L, Shi C, Guo F, Chen A, Cao X, Wan M: Mesenchymal Stem Cells Recruited by Active TGFβ Contribute to Osteogenic Vascular Calcification. Stem Cells Dev. 2014, in press.10.1089/scd.2013.0528
- 15. McCulloch, Till JE. The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiat Res. 1960, 13:115-25.10.2307/3570877
- 16. Goodman JW, Hodgson GS: Evidence for stem cells in the peripheral blood of mice. Blood. 1962, 19:702-14.10.1182/blood.V19.6.702.702
- 17. Massberg S, von Andrian UH: Novel trafficking routes for hematopoietic stem and progenitor cells. Ann N Y Acad Sci. 2009, 1176:87-93.10.1111/j.1749-6632.2009.04609.x
- 18. Fischer KD, Agrawal DK : Hematopoietic Stem and Progenitor Cells in Inflammation and Allergy. Front Immunol. 2013, 4 (4):428.
- 19. Utter GH, Lee TH, Rivers RM, Montalvo L, Wen L, Chafets DM, Reed WF, Busch MP: Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion. 2008, 48(8):1609-1510.1111/j.1537-2995.2008.01758.x
- 20. Brunet de la Grange P, Vlaski M, Duchez P, Chevaleyre J, Lapostolle V, Boiron JM, Praloran V, Ivanovic Z: Long-term repopulating hematopoietic stem cells and “side population” in human steady state peripheral blood. Stem Cell Res. 2013, 11(1):625-33.10.1016/j.scr.2013.04.003
- 21. Kovačević M, Božić T, Jovčić G, Petakov M, Bugarski D, Stanković J, Ivanović Z: 2001. Pig bone marrow and peripheral blood granulocyte-macrophage progenitor cells. Acta Veterinaria (Beograd), 51(1): 15-26.
- 22. Dutra HS, Rossi MI, Azevedo SP, el-Cheikh MC, Borojevic R: Haematopoietic capacity of colony-forming cells mobilized in hepatic inflammatory reactions as compared to that of normal bone marrow cells. Res Immunol. 1997, 148(7):437-44.10.1016/S0923-2494(97)82666-1
- 23. Kovačević M, Božić T, Ivanović Zoran: Erythroid progenitor cells from pig bone marrow and peripheral blood. Veterinary Journal. 1999, 158: 196-203.10.1053/tvjl.1999.0382
- 24. Kovačević M, Božić T, Pavlović V, Petakov Marijana, Bugarski Diana, Jovčić Gordana, Ivanović Zoran: Pig bone marrow and peripheral blood erythroid progenitor cells in S phase of the cell cycle. Acta Veterinaria (Beograd) 2000, 50 (4): 207-214.
- 25. Brockbank KG: Circulating erythroid progenitors in normal and anemic rabbits. Blut. 1983, 47(3):131-7.10.1007/BF00320174
- 26. Eaves AC, Henkelman DH, Eaves CJ: Abnormal erythropoiesis in the myeloproliferative disorders: an analysis of underlying cellular and humoral mechanisms. Scand J Haematol. 1982, 29(5):373-80.
- 27. Beguin Y, Fillet G, Bury J, Fairon Y: Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis. Am J Hematol. 1989, 32(2):123-8.10.1002/ajh.2830320209
- 28. Paulson RF, Shi L, Wu DC: Stress erythropoiesis: new signals and new stress progenitor cells. Curr Opin Hematol. 2011, 18(3):139-45.10.1097/MOH.0b013e32834521c8
- 29. Nichol JL, Hornkohl AC, Choi ES, Hokom MM, Ponting I, Schuening FW, Hunt P: Enrichment and characterization of peripheral blood-derived megakaryocyte progenitors that mature in short-term liquid culture. Stem Cells. 1994, 12(5):494-505.10.1002/stem.5530120505
- 30. Rivière C, Subra F, Cohen-Solal K, Cordette-Lagarde V, Letestu R, Auclair C, Vainchenker W, Louache F: Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesis. Blood. 1999, 93(5):1511-23.10.1182/blood.V93.5.1511
- 31. Boisset JC, van Cappellen W, Andrieu-Soler C, Galjart N, Dzierzak E, Robin C: In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature. 2010, 464(7285):116-20.10.1038/nature08764
- 32. Lin Y, Yoder MC, Yoshimoto M: Lymphoid progenitor emergence in the murine embryo and yolk sac precedes stem cell detection: Stem Cells Dev. 2014, 23(11):1168-77.10.1089/scd.2013.0536
- 33. Moore BB, Murray L, Das A, Wilke CA, Herrygers AB, Toews GB: The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol. 2006, 35(2):175-81.10.1165/rcmb.2005-0239OC
- 34. Delassus S, Cumano A: Circulation of hematopoietic progenitors in the mouse embryo. Immunity. 1996, 4(1):97-106.10.1016/S1074-7613(00)80302-7
- 35. Chen C, Zeng L, Ding S, Xu K: Adult endothelial progenitor cells retain hematopoiesis potential. Transplant Proc. 2010, 42(9):3745-9.10.1016/j.transproceed.2010.07.09421094850
- 36. Körbling M, Freireich EJ: Twenty-five years of peripheral blood stem cell transplantation. Blood. 2011, 117(24):6411-6.10.1182/blood-2010-12-32221421460243
- 37. Richman CM, Weiner RS, Yankee RA: Increase in circulating stem cells following chemotherapy in man. Blood. 1976, 47(6):1031-9.10.1182/blood.V47.6.1031.1031
- 38. Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD: Granulocytemacrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet. 1988, 28(8596):1194-8.
- 39. Ivanovic Z, Kovacevic-Filipovic M, Jeanne M, Ardilouze L, Bertot A, Szyporta M, Hermitte F, Lafarge X, Duchez P, Vlaski M, Milpied N, Pavlovic M, Praloran V, Boiron JM: CD34+ cells obtained from “good mobilizers” are more activated and exhibit lower ex vivo expansion efficiency than their counterparts from “poor mobilizers”. Transfusion. 2010, 50(1):120-7.10.1111/j.1537-2995.2009.02436.x19821946
- 40. Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Kröger N, Farge-Bancel D, Gaspar HB, Marsh J, Mohty M, Peters C, Sureda A, Velardi A, Ruiz de Elvira C, Madrigal A: European Group for Blood and Marrow Transplantation. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant. 2013, 48(9):1161-7.10.1038/bmt.2013.51376351723584439
- 41. Vlaski M, Lafarge X, Chevaleyre J, Duchez P, Boiron JM, Ivanovic Z: Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPOrelated downstream tuning and a tool for the optimization of red blood cell production ex vivo. Exp Hematol. 2009, 37(5):573-84.10.1016/j.exphem.2009.01.00719375648
- 42. Filippone C, Franssila R, Kumar A, Saikko L, Kovanen PE, Söderlund-Venermo M, Hedman K: Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence. PLoS One. 2010, 5(3):e9496-9504.10.1371/journal.pone.0009496283048720209110
- 43. Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, McNiece IK, Ivanovic Z, Caraux J, Marit G, Reiffers J. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion. 2006, 46(11):1934-42.10.1111/j.1537-2995.2006.01001.x17076849
- 44. Escobar C, Grindem C, Neel JA, Suter SE: Hematologic changes after total body irradiation and autologous transplantation of hematopoietic peripheral blood progenitor cells in dogs with lymphoma. Vet Pathol. 2012, 49(2):341-3.10.1177/030098581141072121670196
- 45. Warry EE, Willcox JL, Suter SE: Autologous peripheral blood hematopoietic cell transplantation in dogs with T-cell lymphoma. J Vet Intern Med. 2014, 28(2):529-3710.1111/jvim.12302485799324467413
- 46. Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ: Cryopreservation of hematopoietic stem cells. Am J Hematol. 2007, 82(6):463-72.10.1002/ajh.20707207552517266054
- 47. Jeanne M, Kovacevic-Filipovic M, Szyporta M, Vlaski M, Hermitte F, Lafarge X, Duchez P, Boiron JM, Praloran V, Ivanovic Z: Low-oxygen and high-carbon-dioxide atmosphere improves the conservation of hematopoietic progenitors in hypothermia. Transfusion. 2009, 49(8):1738-4610.1111/j.1537-2995.2009.02191.x19413727
- 48. Vlaski M, Negroni L, Kovacevic-Filipovic M, Guibert C, Brunet de la Grange P, Rossignol R, Chevaleyre J, Duchez P, Lafarge X, Praloran V, Schmitter JM, Ivanovic Z: Hypoxia/ hypercapnia-induced adaptation maintains functional capacity of cord blood stem and progenitor cells at 4ºC. J Cell Physiology. 2014, in press10.1002/jcp.2467824912010
- 49. Jacome-Galarza CE, Lee SK, Lorenzo JA, Aguila HL: Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery. J Bone Miner Res. 2013, 28(5):1203-13.10.1002/jbmr.1822362545423165930
- 50. Charles JF, Hsu LY, Niemi EC, Weiss A, Aliprantis AO, Nakamura MC: Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function.J Clin Invest. 2012, 122(12):4592-605.10.1172/JCI60920353353223114597
- 51. Nijweide PJ, Burger EH, Feyen JH: Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev. 1986, 66(4):855-86.10.1152/physrev.1986.66.4.8553532144
- 52. Martin TJ: Historically significant events in the discovery of RANK/RANKL/OPG. World J Orthop. 2013, 4(4):186-197.10.5312/wjo.v4.i4.186380123824147254
- 53. Muto A, Mizoguchi T, Udagawa N, Ito S, Kawahara I, Abiko Y, Arai A, Harada S, Kobayashi Y, Nakamichi Y, Penninger JM, Noguchi T, Takahashi N: Lineage-committed osteoclast precursors circulate in blood and settle down into bone. J Bone Miner Res. 2011, 26(12):2978-90.10.1002/jbmr.49021898588
- 54. Erices A, Conget P, Minguell JJ: Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000, 109(1):235-42.10.1046/j.1365-2141.2000.01986.x10848804
- 55. Li P, Schwarz EM, O’Keefe RJ, Ma L, Looney RJ, Ritchlin CT, Boyce BF, Xing L: Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum. 2004, 50(1):265-76.10.1002/art.1141914730625
- 56. Tjoa ST, de Vries TJ, Schoenmaker T, Kelder A, Loos BG, Everts V: Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor. J Clin Periodontol. 2008, 35(7):568-75.10.1111/j.1600-051X.2008.01241.x18435789
- 57. Caprioli A, Jaffredo T, Gautier R, Dubourg C, Dieterlen-Lièvre F: Blood-borne seeding by hematopoietic and endothelial precursors from the allantois. Proc Natl Acad Sci U S A. 1998, 95(4):1641-6.10.1073/pnas.95.4.1641191309465069
- 58. Pardanaud L, Luton D, Prigent M, Bourcheix LM, Catala M, Dieterlen-Lievre F : Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development. 1996, 122(5):1363-71.10.1242/dev.122.5.13638625825
- 59. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997, 275(5302):964-7.10.1126/science.275.5302.9649020076
- 60. Yoder MC: Human endothelial progenitor cells. Cold Spring Harb Perspect Med. 2012, 2(7):a00669210.1101/cshperspect.a006692338594622762017
- 61. Favre J, Terborg N, Horrevoets AJ: The diverse identity of angiogenic monocytes. Eur J Clin Invest. 2013, 43(1):100-7.
- 62. Rehman J, Li J, Orschell CM, March KL. Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003, 107(8):1164-9.10.1161/01.CIR.0000058702.69484.A012615796
- 63. Liu JM, Lawrence F, Kovacevic M, Bignon J, Papadimitriou E, Lallemand JY, Katsoris P, Potier P, Fromes Y, Wdzieczak-Bakala J. The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood. 2003, 101(8):3014-20.10.1182/blood-2002-07-231512480715
- 64. Fromes Y, Liu JM, Kovacevic M, Bignon J, Wdzieczak-Bakala J: The tetrapeptide acetylserine- aspartyl-lysine-proline improves skin flap survival and accelerates wound healing. Wound Repair Regen. 2006, 14(3):306-12.10.1111/j.1743-6109.2006.00125.x16808809
- 65. Silvestre JS, Smadja DM, Lévy BI: Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiol Rev. 2013, 93(4):1743-802.10.1152/physrev.00006.201324137021
- 66. Werner N, Nickenig G: Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med. 2006, 10(2):318-32.10.1111/j.1582-4934.2006.tb00402.x393312416796802
- 67. Gössl M, Mödder UI, Gulati R, Rihal CS, Prasad A, Loeffler D, Lerman LO, Khosla S, Lerman A: Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J. 2010, 31(23):2909-14.10.1093/eurheartj/ehq373299595320935001
- 68. Peris P, Atkinson EJ, Gössl M, Kane TL, McCready LK, Lerman A, Khosla S, McGregor UI: Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. Mayo Clin Proc. 2013, 88(1):46-55.10.1016/j.mayocp.2012.08.019365931623228561
- 69. Krenning G, Zeisberg EM, Kalluri R: The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol. 2010, 225(3):631-7.10.1002/jcp.22322309850320635395
- 70. van der Spoel TI, Jansen of Lorkeers SJ, Agostoni P, van Belle E, Gyöngyösi M, Sluijter JP, Cramer MJ, Doevendans PA, Chamuleau SA: Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc Res. 2011, 91(4):649-58.10.1093/cvr/cvr11321498423
- 71. Mitchell AJ, Sabondjian E, Blackwood KJ, Sykes J, Deans L, Feng Q, Stodilka RZ, Prato FS, Wisenberg G: Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction. Int J Cardiovasc Imaging. 2013, 29(2):497-504.10.1007/s10554-012-0086-5356095622736429
- 72. Jantzen AE, Lane WO, Gage SM, Haseltine JM, Galinat LJ, Jamiolkowski RM, Lin FH, Truskey GA, Achneck HE: Autologous endothelial progenitor cell-seeding technology and biocompatibility testing for cardiovascular devices in large animal model. J Vis Exp. 2011, 55: e3197-3205.10.3791/3197323020421931293
- 73. Friedenstein, A.J.,I.I. Piatetzky-Shapiro, K.V. Petrakova: Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 1966, 16:381-390.10.1242/dev.16.3.381
- 74. Friedenstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970, 3(4):393-403.
- 75. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV: Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974, 17(4):331-40.10.1097/00007890-197404000-000014150881
- 76. Caplan AI: Mesenchymal stem cells. J Orthop Res. 1991, 9(5):641-50.10.1002/jor.11000905041870029
- 77. Luria EA, Panasyuk AF, Friedenstein A:. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion. 1971, 11(6):345-9.10.1111/j.1537-2995.1971.tb04426.x5136066
- 78. Fernández M, Simon V, Herrera G, Cao C, Del Favero H, Minguell JJ: Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant. 1997, 20(4):265-71.10.1038/sj.bmt.17008909285540
- 79. Lazarus HM, Haynesworth SE, Gerson SL, Caplan AI: Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother. 1997, 6(5):447-55.10.1089/scd.1.1997.6.4479368181
- 80. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 2003, 121(2):368-74.10.1046/j.1365-2141.2003.04284.x12694261
- 81. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN: Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000, 2(6):477-88.10.1186/ar1301782011056678
- 82. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol. 2001,153(5):1133-40.10.1083/jcb.153.5.1133217432211381097
- 83. Kuznetsov SA, Mankani MH, Leet AI, Ziran N, Gronthos S, Robey PG: Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells. 2007, 25(7):1830-9.10.1634/stemcells.2007-014017464083
- 84. Divya MS, Roshin GE, Divya TS, Rasheed VA, Santhoshkumar TR, Elizabeth KE, James J, Pillai RM: Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation. Stem Cell Res Ther. 2012, 19(6):57-73.
- 85. Huss R, Lange C, Weissinger EM, Kolb HJ, Thalmeier K: Evidence of peripheral bloodderived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells. 2000, 18(4):252-60.10.1634/stemcells.18-4-25210924091
- 86. Han X, Liu H, Wang D, Su F, Zhang Y, Zhou W, Li S, Yang R: Alveolar bone regeneration around immediate implants using an injectable nHAC/CSH loaded with autogenic bloodacquired mesenchymal progenitor cells: an experimental study in the dog mandible. Clin Implant Dent Relat Res. 2013, 15(3):390-401.10.1111/j.1708-8208.2011.00373.x21745333
- 87. Kang BJ, Ryu HH, Park SS, Koyama Y, Kikuchi M, Woo HM, Kim WH, Kweon OK: Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton’s jelly for treating bone defects. J Vet Sci. 2012, 13(3):299-310.10.4142/jvs.2012.13.3.299346740623000587
- 88. Ryu HH, Kang BJ, Park SS, Kim Y, Sung GJ, Woo HM, Kim WH, Kweon OK: Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton’s jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J Vet Med Sci. 2012, 74(12):1617-30.10.1292/jvms.12-006522878503
- 89. Lim JH, Byeon YE, Ryu HH, Jeong YH, Lee YW, Kim WH, Kang KS, Kweon OK: Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J Vet Sci. 2007, 8(3):275-82.10.4142/jvs.2007.8.3.275286813517679775
- 90. Koerner J, Nesic D, Romero JD, Brehm W, Mainil-Varlet P, Grogan SP: Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells. 2006, 24(6):1613-9.10.1634/stemcells.2005-026416769763
- 91. Giovannini S, Brehm W, Mainil-Varlet P, Nesic D: Multilineage differentiation potential of equine blood-derived fibroblast-like cells. Differentiation. 2008, 76(2):118-2910.1111/j.1432-0436.2007.00207.x17697129
- 92. Koch TG, Heerkens T, Thomsen PD, Betts DH: Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol. 2007, 30(7):26-35.
- 93. Marfe G, Rotta G, De Martino L, Tafani M, Fiorito F, Di Stefano C, Polettini M, Ranalli M, Russo MA, Gambacurta A: A new clinical approach: use of blood-derived stem cells (BDSCs) for superficial digital flexor tendon injuries in horses. Life Sci. 2012, 90(21-22):825-30.10.1016/j.lfs.2012.03.00422480518
- 94. Broeckx S, Borena BM, Zimmerman M, Mariën T, Seys B, Suls M, Duchateau L, Spaas JH: Intravenous Application of Allogenic Peripheral Blood-Derived Mesenchymal Stem Cells: a Safety Assessment in 291 Equine Recipients. Curr Stem Cell Res Ther. 2014, DOI: 10.2174/1574888X09666140220003847.10.2174/1574888X0966614022000384724548143
- 95. Ding Y, Li S, Nie G: Nanotechnological strategies for therapeutic targeting of tumor vasculature. Nanomedicine (Lond). 2013, 8(7):1209-22.10.2217/nnm.13.10623837858
- 96. Fukuda K, Fujita J: Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. Kidney Int. 2005, 68(5):1940-3.10.1111/j.1523-1755.2005.00624.x16221170
- 97. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994, 1(1):71-81.10.1007/BF03403533
- 98. Chesney J, Bacher M, Bender A, Bucala R: The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A.1997, 94(12):6307-12.10.1073/pnas.94.12.6307210459177213
- 99. Suga H, Rennert RC, Rodrigues M, Sorkin M, Glotzbach JP, Januszyk M, Fujiwara T, Longaker MT, Gurtner GC: Tracking the elusive fibrocyte: identification and characterization of collagen-producing hematopoietic lineage cells during murine wound healing. Stem Cells. 2014, 32(5):1347-60.10.1002/stem.1648409648824446236
- 100. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN: Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 2001,15(12):2215-24.10.1096/fj.01-0049com11641248
- 101. Isgrò M, Bianchetti L, Marini MA, Bellini A, Schmidt M, Mattoli S: The C-C motif chemokine ligands CCL5, CCL11, and CCL24 induce the migration of circulating fibrocytes from patients with severe asthma. Mucosal Immunol. 2013, 6(4):718-27.10.1038/mi.2012.10923149666
- 102. Scholten D, Reichart D, Paik YH, Lindert J, Bhattacharya J, Glass CK, Brenner DA, Kisseleva T: Migration of fibrocytes in fibrogenic liver injury. Am J Pathol. 2011, 179(1):189-98.10.1016/j.ajpath.2011.03.049312378121703401
- 103. Mackinnon A, Forbes S: Bone marrow contributions to fibrosis. Biochim Biophys Acta. 2013, 1832(7):955-61.10.1016/j.bbadis.2013.01.02223385196
- 104. Pilling D, Roife D, Wang M, Ronkainen SD, Crawford JR, Travis EL, Gomer RH: Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol. 2007, 179(6):4035-44.10.4049/jimmunol.179.6.4035448234917785842
- 105. Knežević M, Gledić D, Kukolj V, Knežević Dj, Jovanović M, Božić T, Aleksić-Kovačević S: Expression of α-SMA, desmin and vimentin in canine liver with fibrosis. Acta Vet (Beograd) 2009, 59(4):361-370.10.2298/AVB0904361K
- 106. Aleksić-Kovačević S, Kukolj V, Kureljušić B, Marinković D, Knežević Dj, Ignjatović I, Jovanović M, Knežević M, Gledić D: Role of hepatic stellate cells (HSCs) in development of hepatic fibrosis in cats with polycystic kidney disease (PKD). Acta Vet (Beograd) 2010, 60(4):391-400.10.2298/AVB1004391A
- 107. Lilja-Maula L, Syrjä P, Laurila HP, Sutinen E, Rönty M, Koli K, Rajamäki MM, Myllärniemi M: Comparative Study of Transforming Growth Factor-β Signalling and Regulatory Molecules in Human and Canine Idiopathic Pulmonary Fibrosis. J Comp Pathol. 2013, 150(4):399-407.
- 108. Williams KJ: Gamma herpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodents. Vet Pathol. 2014, 51(2):372-84.10.1177/030098581452183824569614
- 109. Marinković D, Kukolj V, Aleksić-Kovačević S, Jovanović M, Knežević M: The role of hepatic myofibroblasts in liver cirrhosis in fallow deer (Dama dama) naturally infected with giant liver fluke (Fascioloides magna). BMC Vet Res. 2013, 6(9):45-51.
- 110. Roman J, Brown KK, Olson A, Corcoran BM, Williams KJ: ATS Comparative Biology of Lung Fibrosis Working Group. An official American Thoracic Society workshop report: comparative pathobiology of fibrosing lung disorders in humans and domestic animals. Ann Am Thorac Soc. 2013, 10(6):S224-9.10.1513/AnnalsATS.201309-321ST24364785
- 111. Horňák S, Harvanová D, Ledecký V, Hluchý M, Valenčáková-Agyagosová A, Amrichová J, Rosocha J, Vaško G, Švihla R, Petrovič V. Reparation of chondral defects in rabbits by autologous and allogenous chondrocytes seeded on collagen/hyaluronan scaffold or suspended in fibrin glue. Acta veterinaria-Beograd, 64 (2014):61-72.10.2478/acve-2014-0007
- 112. Arsenović-Ranin N, Nacka-Aleksić M, Djikić J, Perišić M, Kosec D, Pilipović I, Stojić- Vukanić Z, Leposavić G: Thymocyte apoptosis and proliferation modeling during rat thymic involution is influenced by ovarian hormones in a thymocyte subset-specific manner. Acta veterinaria-Beograd, 2013, 63 (1): 3-2110.2298/AVB1301003A
- 113. Vojvodić D, Miljanović O, Đurđević D, Gatarić S, Stanojević I, Obradović D, Šurbatović M, Francuski J: Effects of different anesthetic agents on GM-CSF, MCP1, IL1 and TNF levels in rat sepsis mode. Acta veterinaria-Beograd, 2013 63(2-3):125-136.10.2298/AVB1303125V
- 114. Lamagna C, Bergers G: The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol. 2006, 80(4):677-81.10.1189/jlb.050630916888086
- 115. Merkulova-Rainon T, Broquères-You D, Kubis N, Silvestre JS, Lévy BI: Towards the therapeutic use of vascular smooth muscle progenitor cells. Cardiovasc Res. 2012, 95(2):205-14.10.1093/cvr/cvs09722354897
- 116. Pignolo RJ, Kassem M: Circulating osteogenic cells: implications for injury, repair, and regeneration. J Bone Miner Res. 2011, 26(8):1685-93.10.1002/jbmr.37021538513
- 117. Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba- Surma E, Czajka R, Wojakowski W, Machalinski B, Ratajczak MZ: Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia. 2007, 21(2):297-303.10.1038/sj.leu.240447017136117